Breakdown | ||||
Mar 2024 | Mar 2023 | Mar 2022 | Mar 2021 | Mar 2020 |
---|---|---|---|---|
Income Statement | Total Revenue | |||
13.04B | 11.93B | 10.89B | 9.16B | 10.18B | Gross Profit |
4.46B | 4.14B | 3.75B | 2.91B | 3.59B | EBIT |
714.20M | 515.10M | 572.20M | 26.10M | 254.80M | EBITDA |
1.32B | 1.20B | 1.12B | 629.20M | 1.07B | Net Income Common Stockholders |
431.20M | 363.40M | 306.60M | -201.20M | 23.70M |
Balance Sheet | Cash, Cash Equivalents and Short-Term Investments | |||
1.03B | 1.08B | 1.22B | 692.80M | 260.10M | Total Assets |
8.68B | 9.10B | 9.44B | 8.64B | 10.18B | Total Debt |
3.13B | 3.63B | 3.81B | 4.09B | 4.18B | Net Debt |
2.11B | 2.56B | 2.61B | 3.42B | 3.93B | Total Liabilities |
5.85B | 6.28B | 6.53B | 6.35B | 6.48B | Stockholders Equity |
2.83B | 2.81B | 2.91B | 2.28B | 3.70B |
Cash Flow | Free Cash Flow | |||
872.40M | 619.60M | 1.12B | 664.20M | 644.50M | Operating Cash Flow |
1.30B | 1.03B | 1.38B | 870.90M | 973.10M | Investing Cash Flow |
-435.30M | -516.60M | -245.70M | -192.60M | -765.70M | Financing Cash Flow |
-909.80M | -643.80M | -595.90M | -244.00M | -256.90M |
Name | Overall Rating | Market Cap | P/E Ratio | ROE | Dividend Yield | Revenue Growth | EPS Growth |
---|---|---|---|---|---|---|---|
78 Outperform | $6.25B | 11.05 | 30.93% | 0.25% | -3.94% | -17.78% | |
73 Outperform | $10.22B | 27.24 | 10.27% | 1.37% | 10.48% | 26.57% | |
73 Outperform | $3.05B | 5.68 | 12.92% | 6.49% | -3.77% | 4607.98% | |
72 Outperform | $7.78B | 9.09 | 29.16% | 3.16% | 1.07% | 28.03% | |
62 Neutral | $6.82B | 11.05 | 2.80% | 4.32% | 2.67% | -24.92% | |
60 Neutral | $4.12B | 14.17 | 29.58% | 3.08% | 2.20% | 120.00% | |
59 Neutral | $909.78M | 7.52 | 3.19% | 6.16% | -7.03% | -56.59% |